Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Monika Reczek"'
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Background: The emergence of new antileukemic drugs, including Bruton tyrosine kinase inhibitors (BTKis), phosphoinositide 3-kinase inhibitors (PI3Kis), and B-cell lymphoma 2 antagonists (BCL-2a), has significantly improved the outcomes for patients
Externí odkaz:
https://doaj.org/article/36ff0b55dd9b49d9b97f5a7cea37aafd
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Background: The recent development of new antileukemic therapies (anti-CD20 monoclonal antibodies, Bruton tyrosine kinase inhbitors, phosphoinositide 3-kinase inhibitors, and B-cell lymyphoma-2 antagonists) improved the progression-free survival (PFS
Externí odkaz:
https://doaj.org/article/33d6180fec3844ea9a884938f5fc039f
Publikováno v:
Therapeutic Advances in Medical Oncology; 7/31/2024, p1-19, 19p
Publikováno v:
Immunotherapy Weekly; 10/29/2024, p988-988, 1p
Publikováno v:
Immunotherapy Weekly; 8/22/2024, p2136-2136, 1p